These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32229549)

  • 21. Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan.
    Okumura H; Ueyama M; Shoji S; English M
    J Infect Chemother; 2020 Jun; 26(6):611-618. PubMed ID: 32165072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.
    Fischer M; Sipe BW; Rogers NA; Cook GK; Robb BW; Vuppalanchi R; Rex DK
    Aliment Pharmacol Ther; 2015 Aug; 42(4):470-6. PubMed ID: 26096320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile infection: review.
    Czepiel J; Dróżdż M; Pituch H; Kuijper EJ; Perucki W; Mielimonka A; Goldman S; Wultańska D; Garlicki A; Biesiada G
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1211-1221. PubMed ID: 30945014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Faecal microbiota transplantation for
    Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
    United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection.
    Tieu JD; Williams RJ; Skrepnek GH; Gentry CA
    J Clin Pharm Ther; 2019 Apr; 44(2):220-228. PubMed ID: 30350418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile, the Difficult "Kloster" Fuelled by Antibiotics.
    Dicks LMT; Mikkelsen LS; Brandsborg E; Marcotte H
    Curr Microbiol; 2019 Jun; 76(6):774-782. PubMed ID: 30084095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.
    Gravito-Soares M; Gravito-Soares E; Portela F; Ferreira M; Sofia C
    Rev Esp Enferm Dig; 2017 Jun; 109(6):473-476. PubMed ID: 28506071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Clostridium difficile-associated diarrhea and colitis.
    Gerding DN
    Curr Top Microbiol Immunol; 2000; 250():127-39. PubMed ID: 10981361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
    Bossé D; Lemire C; Ruel J; Cantin AM; Ménard F; Valiquette L
    Infection; 2013 Apr; 41(2):579-82. PubMed ID: 22996384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal transplant clinical trials for 
    Khanna S
    Future Microbiol; 2020 Jun; 15():709-712. PubMed ID: 32677453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection.
    Pecere S; Sabatelli M; Fantoni M; Ianiro G; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2015 Oct; 42(8):1030. PubMed ID: 26374258
    [No Abstract]   [Full Text] [Related]  

  • 34. Faecal microbiota transplantation for eradication of co-infection with
    Bahl MI; Jørgensen SMD; Skriver AH; Larsen NA; Wang M; Licht TR; Dahlerup JF; Hvas CL
    Scand J Gastroenterol; 2020 May; 55(5):626-630. PubMed ID: 32324085
    [No Abstract]   [Full Text] [Related]  

  • 35. Cutting edges in Clostridioides difficile infections.
    Durovic A; Tschudin-Sutter S
    Swiss Med Wkly; 2021 Sep; 151():w30033. PubMed ID: 34652093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease.
    Ramesh MS; Yee J
    Adv Chronic Kidney Dis; 2019 Jan; 26(1):30-34. PubMed ID: 30876614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome.
    Camacho-Ortiz A; Gutiérrez-Delgado EM; Garcia-Mazcorro JF; Mendoza-Olazarán S; Martínez-Meléndez A; Palau-Davila L; Baines SD; Maldonado-Garza H; Garza-González E
    PLoS One; 2017; 12(12):e0189768. PubMed ID: 29261736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fidaxomicin versus vancomycin for Clostridium difficile infection.
    Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
    N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fidaxomicin for the treatment of
    Skinner AM; Scardina T; Kociolek LK
    Future Microbiol; 2020 Jul; 15(11):967-979. PubMed ID: 32715754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection--authors' reply.
    Fischer M; Rex DK; Sipe BW
    Aliment Pharmacol Ther; 2015 Oct; 42(8):1031. PubMed ID: 26374259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.